Company News

Dyne Therapeutics narrows Q4 loss to $0.73/share vs $0.76 estimate, shares jump 11.8% on improving trajectory and $893M cash position.

BioNTech posts wider-than-expected Q4 loss of $0.33/share as COVID vaccine revenue plunges 24% year-over-year; founders to exit for new mRNA…

HPE maintains its $0.14 quarterly dividend with a 2.7% yield; ex-date March 24, 2026.

SolarEdge narrows Q4 loss to $0.14/share vs $0.24 estimate, stock jumps 10% despite cautious Q1 guidance of $290M-$320M revenue.

CRISPR Therapeutics posts wider-than-expected Q4 loss of $1.37/share on zero revenue; shares sink 10% as cash burn accelerates.

Broadwind Energy reports Q4 loss of $0.05 per share on revenue of $37M, up 10% year-over-year, with fiscal 2026 guidance…

Acacia Research reports Q4 adjusted EPS of $0.03, up 122.5% year-over-year, with revenue of $50.1M rising 2.6% from the prior…

Acacia Research swings to $0.03 adjusted EPS in Q4 2025, matching prior quarter and reversing year-ago loss, as revenue holds…

BridgeBio posts wider-than-expected Q4 loss of $0.94/share on $154.2M revenue; stock surges 13% despite 50.6% earnings miss.

Dianthus Therapeutics posts wider-than-expected Q4 loss of $1.43/share on collapsing revenue, yet shares surge 21.5% on pipeline optimism.